Hay, Kevin A <br/><br/>
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.  [electronic resource] 

 -  Blood  11 2017 
 - 2295-2306 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2017-06-793141  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--metabolism<br/>Blood Coagulation Disorders--complications<br/>Cytokines--metabolism<br/>Endothelial Cells--pathology<br/>Female<br/>Fever--etiology<br/>Hematopoiesis<br/>Hemodynamics<br/>Humans<br/>Immunotherapy, Adoptive<br/>Kinetics<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neurotoxicity Syndromes--complications<br/>Receptors, Antigen, T-Cell--metabolism<br/>Risk Factors<br/>Syndrome<br/>T-Lymphocytes--immunology<br/>Treatment Outcome<br/>Young Adult